SOHO 4th Italian Conference

www.sohoitaly.com

 

SOHO 4th Italian Conference
C

SOHO Italy 2022 on the Phase 2/3 HARBOR Study: BLU-263 in Patients With Indolent Systemic Mastocytosis and Monoclonal Mast Cell Activation Syndrome

By SOHO 4th Italian Conference FEATURING Cristina Papayannidis
By SOHO 4th Italian Conference FEATURING Cristina Papayannidis
7 views
December 1, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
CAR-T and Benign Hematology
07:05
SOHO 4th Italian Conference

SOHO Italy 2022: Anxiety, Depression, Distress, & Resilience in …

Feat. G. Cancemi
06:15
SOHO 4th Italian Conference

SOHO Italy 2022 on the Phase 2/3 HARBOR Study: BLU-263 in Patients W…

Feat. C. Papayannidis
11:10
SOHO 4th Italian Conference

SOHO Italy 2022: The Dark Side of CAR-T - The Point of View From the…

Feat. G. Bolondi